Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented

Nair Campos1, Fernando Magro, Ana Rita Castro

  • 1CEBIMED - Biomedicine Research Center, Health Sciences Faculty, University Fernando Pessoa, Porto, Portugal.

Immunobiology
|January 29, 2011
PubMed

Insights

Macrophages from Crohn's disease (CD) patients exhibit altered inflammatory responses to gut bacteria. CD patient macrophages show reduced TNF-α and IL-10, but increased IL-23, potentially worsening inflammation.

Area of Science:

  • Immunology
  • Gastroenterology
  • Microbiology

Background:

  • Macrophage dysfunction is linked to Crohn's disease (CD) pathogenesis.
  • The response of CD patient macrophages to specific bacteria like Mycobacterium avium subsp. paratuberculosis (MAP) remains unclear.

Purpose of the Study:

  • To investigate the inflammatory response of macrophages from CD patients upon infection with MAP, M. avium subsp. avium (MA), and commensal bacteria.
  • To compare these responses with those of macrophages from ulcerative colitis (UC) patients and healthy controls.

Main Methods:

  • Human peripheral blood monocyte-derived macrophages were isolated from CD patients, UC patients, and controls.
  • Macrophages were infected in vitro with MAP, MA, Escherichia coli, or Enterococcus faecalis.
  • Cytokine levels (TNF-α, IL-23, IL-12, IL-10) and cell surface receptor expression (CD-40, TLR-2, TLR-4) were measured.

Main Results:

  • CD patient macrophages displayed impaired TNF-α secretion but augmented IL-23 and preserved IL-12 secretion and CD-40 expression after bacterial challenge.
  • Macrophages from CD patients showed significantly lower IL-10 secretion.
  • These altered cytokine profiles were not specific to MAP, occurring with other tested bacteria.
  • UC patient macrophages showed less compromised TNF-α synthesis and preserved IL-10 secretion compared to CD macrophages.

Conclusions:

  • Macrophages from CD patients exhibit a distinct inflammatory profile characterized by reduced TNF-α and IL-10, and increased IL-23 production in response to bacterial stimuli.
  • This dysregulated immune response in CD macrophages may contribute to the chronic inflammation characteristic of the disease.
  • The findings highlight potential therapeutic targets related to macrophage function in Crohn's disease management.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...